OrbiMed Capital GP IX LLC — SEC insider filings

SEC reporting owner CIK 1920574. 7 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-11-05 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Braveheart Bio, Inc. (BRVE)Director, 10% owner12 legs · 1,940,000 sh · $34,920,000—2
WINDWARD BIO GROUP AG (WWB)Director, 10% owner21 leg · 1,176,471 sh · $20,000,007—7
Shattuck Labs, Inc. (STTK)Director32 legs · 6,306,127 sh · $5,471,826—10
Lomond Therapeutics Holdings, Inc.Director1——13

Insider filings — OrbiMed Capital GP IX LLC

FiledFormIssuerReported transactionsSource
2026-11-184WINDWARD BIO GROUP AG (WWB)
jointly with ORBIMED ADVISORS LLC
Purchase (P): 1,176,471 @ $17 · Conversion (C): 3,561,936 · Conversion (C): 1,611,008 · Option exercise (M): 216,668 @ $0.02 · Tax withholding (F): 232 @ $17 · Conversion (C): 3,561,936 (derivative) @ $0 · +2 moreEDGAR
2026-11-123WINDWARD BIO GROUP AG (WWB)
jointly with ORBIMED ADVISORS LLC
Holdings only — no transactions reportedEDGAR
2026-08-114Braveheart Bio, Inc. (BRVE)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC
Conversion (C): 9,132,420 · Purchase (P): 1,666,667 @ $18 · Purchase (P): 273,333 @ $18 · Conversion (C): 40,000,000 (derivative) @ $0EDGAR
2026-06-154Shattuck Labs, Inc. (STTK)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC
Purchase (P): 1,041,667 (derivative) · Purchase (P): 208,333 (derivative)EDGAR
2026-06-094Shattuck Labs, Inc. (STTK)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC
Conversion (C): 15,366,490 (derivative) · Conversion (C): 3,073,298 (derivative) · Conversion (C): 15,366,490 (derivative) · Conversion (C): 3,073,298 (derivative)EDGAR
2025-09-024Shattuck Labs, Inc. (STTK)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC
Purchase (P): 5,255,106 @ $0.87 · Purchase (P): 1,051,021 @ $0.87 · Purchase (P): 10,111,384 (derivative) · Purchase (P): 2,022,277 (derivative) · Purchase (P): 15,366,490 (derivative) · Purchase (P): 3,073,298 (derivative)EDGAR
2024-11-054Lomond Therapeutics Holdings, Inc.
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC, OrbiMed Capital GP VIII LLC
Conversion (C): 323,916 @ $3.20 · Conversion (C): 215,146 @ $3.20 · Conversion (C): 389,078 @ $3.60 · Conversion (C): 230,753 @ $3.60 · Conversion (C): 74,613 @ $3.60 · Grant/award (A): 808,894 @ $4 · +7 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1920574 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs